EADV report shows that risankizumab is a consistent performer in psoriasis
Risankizumab performed better in treating psoriasis that appears on the nails, hands and feet, palms and scalp sores.
EADV starts this week in Paris
The European Academy of Dermatology and Venerology (EADV) 2018 meeting takes this week in Paris. Visit our EADV conference news site to follow the developments from Paris.
Optimizing Vitiligo Care: Key Expert Takeaways
Dermatology Conferences and Meetings Calendar: April 2025
Daily Derm Times: March 31, 2025
Patients with Vitiligo Have a Lower Risk of Developing Serious Infections, New Poster Finds